Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/30/6a/6a/306a6a27-5590-6622-dfba-7d6a7d0dbbb0/mza_1420088730083196311.jpg/600x600bb.jpg
CannMed Coffee Talk
Medicinal Genomics
133 episodes
2 weeks ago
Brought to you by Medicinal Genomics & Advanced Nutrients
Show more...
Life Sciences
Health & Fitness,
Science,
Natural Sciences
RSS
All content for CannMed Coffee Talk is the property of Medicinal Genomics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Brought to you by Medicinal Genomics & Advanced Nutrients
Show more...
Life Sciences
Health & Fitness,
Science,
Natural Sciences
https://cannmedevents.com/wp-content/uploads/2025/08/Coffee-Talk-Podcast-EMILY-RACHAELArtboard-1.jpg
Recruitment Challenges for Cannabis Clinical Trials – Emily Lindley, PhD & Rachael Rzasa Lynn, MD
CannMed Coffee Talk
37 minutes 34 seconds
3 months ago
Recruitment Challenges for Cannabis Clinical Trials – Emily Lindley, PhD & Rachael Rzasa Lynn, MD
Dr. Emily Lindley is Assistant Professor of Orthopedics and Director of the Colorado Cannabis Research Consortium. Her team’s research aims to identify non-opioid alternatives for the treatment of chronic musculoskeletal pain. One such alternative that has gained increased recognition in recent years is medical cannabis, and her lab is currently studying the health effects of cannabis and cannabinoids for chronic musculoskeletal pain.



Dr. Rachael Rzasa Lynn is a board certified in pain medicine physician and is an Associate Professor in the Department of Anesthesiology at the University of Colorado, where she is the Associate Program Director for the Pain Medicine Fellowship. Her research includes investigations in opioid pharmacology and the use of cannabis for chronic pain.



Emily and Rachael co-authored a poster presented at the most recent ICRS conference titled, Recruitment Challenges in Clinical Studies of Cannabis



During our conversation, we discussed:




How recruitment for cannabis clinical trials differs from traditional clinical trials



Why prior experience with cannabis is considered a negative for patient recruitment



How legal concerns and stigma can deter cannabis-naive patients from enrolling



Why the particiapnt drop out rate is higher in cannabis trials



How rescheduling may affect patient recruitment future trials




Thanks to This Episode's Sponsor: The Society of Cannabis Clinicians



The Society of Cannabis Clinicians’ Med Cann conference offers a rare opportunity for clinicians to dive deep into the clinical realities and therapeutic potential of medical cannabis and psychedelics. Designed with healthcare providers in mind, their sessions focus on case-based learning, emerging protocols, and real-world challenges—offering practical insights that can be immediately applied in your practice.



Learn more at cannabisclinicians.org and use code "CP15" to receive 15% Off Your Registration



Additional Resources




Recruitment Challenges in Clinical Studies of Cannabis [Poster]



Lindley Lab at the University of Colorado
CannMed Coffee Talk
Brought to you by Medicinal Genomics & Advanced Nutrients